COPD Flashcards

1
Q

is a condition of chronic dyspnea with expiratory airflow limitation that does not significantly fluctuate.

A

Chronic Obstructive Pulmonary Disease (COPD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

has been defined by The Global Initiative for Chronic Obstructive Lung Disease as “apreventableandtreatabledisease with some significant extrapulmonary effects that may contribute to the severity in individual patients.”

A

Chronic Obstructive Pulmonary Disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Chronic Obstructive Pulmonary Disease has been defined by ____ as “apreventableandtreatabledisease with some significant extrapulmonary effects that may contribute to the severity in individual patients.”

A

The Global Initiative for Chronic Obstructive Lung Disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

is a disease of the airways and is defined as the presence ofcoughandsputum productionforat least 3 monthsin each of2 consecutive years.

A

Chronic bronchitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Chronic bronchitis is also termed as

A

“blue bloaters”.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

is a pathologic term that describes anabnormal distention of airspacesbeyond the terminalbronchiolesand destruction of the walls of the alveoli.

A

Pulmonary Emphysema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

People with emphysema are also called

A

“pink puffers”.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

There are two main types of emphysema:

A

panlobular and centrilobular.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

there is destruction of the respiratory bronchiole, alveolar duct, and alveolus.

A

panlobular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

pathologic changes occur mainly in the center of the secondary lobule.

A

centrilobular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

In ___, the airflow limitation is both progressive and associated with an abnormal inflammatory response of thelungsto noxious gases or particles.

A

COPD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

leads to loss of alveolar attachments and a decrease in elastic recoil.

A

Alveolar wall destruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

is thefourthleading cause ofdeathin the United States.

A

COPD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

COPD also account for the death of ____Americans every year.

A

125, 000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Mortality from COPD among men has increased, and in 2005, more men than women died of COPD. T or F

A

F

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Causes of COPD includes environmental factors and host factors. These includes:

A

Smoking
Occupational exposure
Genetic abnormalities

17
Q

Clinical Manifestations COPD

A

Chroniccough
Sputum production
Dyspnea on exertion
Dyspnea at rest
Weight loss
Barrel chest

18
Q

means a broad, deep chest that resembles the shape of a barrel

A

barrel chest

19
Q

This is the singlemost cost-effectiveintervention to reduce the risk of developing COPD and to stop its progression.

A

Smoking cessation

20
Q

There are two major life-threatening complications of COPD:

A

respiratory insufficiency and failure.

21
Q

Assessment and Diagnostic Findings COPD

A

Health history
Pulmonary function studies
Spirometry
ABG
Chest x-ray
CT scan
Screening for alpha1-antitrypsin deficiency
Pulmonary function tests
DLCO test
Bronchogram
Lung scan
Complete blood count
Blood chemistry
Sputum culture
Cytologic examination
Electrocardiogram
ExerciseECG,stresstest

22
Q

is first-line therapyand involves identifying the best medications or combinations of medications taken on a regular schedule for a specific patient COPD

A

Optimization ofbronchodilatormedications

23
Q

Pharmacologic Therapy of COPD

A

Bronchodilators
Corticosteroids
alpha1-antitrypsin augmentation therapy,antibioticagents,mucolyticagents, antitussive agents,vasodilators, andnarcotics.

24
Q

Management of Exacerbations COPD

A

Hospitalization
Oxygen therapy
Antibiotics

25
Patients with COPD also have options for surgery to improve their condition.
Bullectomy Lung Volume Reduction Surgery Lung Transplantation
26
is a surgical option for select patients with bullous emphysema and can help reduce dyspnea and improve lung function.
Bullectomy
27
 is a palliative surgery in patients with homogenous disease or disease that is focused in one area and not widespread throughout the lungs.
Lung volume reduction surgery
28
is a viable option for definitive surgical treatment of end-stage emphysema.
Lung transplantation
29
is used to evaluate airway obstruction, which is determined by the ratio of FEV1 to forced vital capacity.
Spirometry